Hillgene employs a closed automated platform to provide process transfer, optimization, and IND-level production services for products such as CAR-T and TCR-T. From cell activation, transduction, and expansion to cryopreservation, every step is tightly controlled to ensure cell products exhibit high viability, high transduction efficiency, and well-defined efficacy. Our quality systems and data integrity fully meet IND application and clinical trial requirements.